Penile cancer, Secondary cancers
Results
Phase 2
This trial looked at a chemotherapy drug called cabazitaxel to improve treatment for cancer of the penis. Cancer of the penis is also called penile cancer.
It was for men whose cancer had grown into surrounding tissue or had spread elsewhere in the body. This is locally advanced or advanced cancer.
This trial was open for people to join between 2014 and 2017, and the team published the results in 2019.
Recruitment start: 19 December 2014
Recruitment end: 14 February 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Amit Bahl
NIHR Clinical Research Network: Cancer
Sanofi Aventis
University Hospitals Bristol NHS Foundation Trust
Last reviewed: 25 Mar 2021
CRUK internal database number: 12584